Pirkko Tamsen



Born 1959. Active in the company since 2020. PhD, 30 years of experience in the pharmaceutical industry including CEO of several SME and CRO companies as well as experience from large pharmaceutical companies Astra and Kabi. Previous board positions include Alzecure Pharma AB and Örebro University Holding AB.
Shareholding: 229 456 shares.

Mark Beveridge



Born 1978. Active in the company since 2020. B. Com, GradDipCA. More than 15 years of experience in finance and accounting, VP Finance Moberg Pharma, advisor in accounting, insurance and auditing, primarily at Crowe Horwath and Visma Services. Independent consultant within financial control, transaction consultancy and implementation of business systems.
Shareholding: 45 144 shares.

Markus Jerling



Born 1952. Active in the company since 2021. Legal physician, specialist and PhD in clinical pharmacology. Has worked in several specialties including anesthesia. International and broad experience of clinical development in all development phases from both AstraZeneca and companies in Sweden and the USA. Previous positions include Medical Director and Head of Clinical Pharmacology, Global Drug Surveillance, VP of Clinical Research, CMO. Shareholding: 0 shares.